Compare Amphastar Pharmaceuticals Inc (AMPH) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Plby Group Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Plby Group Inc trades at $1.33 (market cap $162.94M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 5.3× Plby Group Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Plby Group Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PLBY | |
|---|---|---|
Market Cap | $868.62M | $162.94M |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $2.71 |
52-Week Low | $16.87 | $1.11 |
Enterprise Value | $1.27B | $308.52M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
